Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARIA | GRFS | CORT | ||
| Company | Ariad Pharm Inc | Grifols S.A. ADR | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 23.95 | 8.13 | 40.95 | ||
| High | 23.99 | 8.25 | 43.37 | ||
| Low | 23.94 | 8.00 | 40.48 | ||
| Latest | 23.99 | 8.24 | 42.49 | ||
| Change | +0.04 | -0.01 | +0.51 | ||
| % Change | +0.17% | -0.12% | +1.21% | ||
| Volume | 7,220,900 | 758,700 | 1,498,200 | ||
| 20-Day Average Volume | 8,662,590 | 839,320 | 2,040,065 | ||
| Previous Close | 23.95 | 8.25 | 41.98 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.79 | 7.94 | 35.72 | ||
| 20-Day Raw Stochastic | 100.00% | 61.59% | 57.45% | ||
| 20-Day Relative Strength | 83.87 | 48.20 | 58.08 | ||
| Weighted Alpha | +164.00 | +9.03 | -6.64 | ||
| Today's Opinion | N/A | 88% Sell | 56% Sell | ||
| Previous Opinion | N/A | 88% Sell | 56% Sell | ||
| Last Month's Opinion | N/A | 56% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.50% since 02/08/17 | +8.14% since 03/26/26 | +10.28% since 03/26/26 | ||
| Low | 23.85 on 02/10/17 | 7.47 on 03/27/26 | 37.15 on 03/27/26 | ||
| High | 23.99 on 02/15/17 | 8.28 on 04/01/26 | 43.37 on 04/02/26 | ||
| 1-Month | |||||
| %Chg | +1.27% since 01/13/17 | -9.35% since 03/02/26 | +18.13% since 03/02/26 | ||
| Low | 23.63 on 01/27/17 | 7.39 on 03/25/26 | 31.81 on 03/13/26 | ||
| High | 23.99 on 02/15/17 | 8.94 on 03/05/26 | 50.40 on 03/25/26 | ||
| 3-Month | |||||
| %Chg | +81.74% since 11/15/16 | -10.82% since 01/02/26 | +11.23% since 01/02/26 | ||
| Low | 11.69 on 12/22/16 | 7.39 on 03/25/26 | 28.66 on 02/19/26 | ||
| High | 23.99 on 02/15/17 | 9.77 on 02/18/26 | 50.40 on 03/25/26 | ||
| 6-Month | |||||
| %Chg | +125.05% since 08/15/16 | -17.76% since 10/02/25 | -50.29% since 10/02/25 | ||
| Low | 8.63 on 11/03/16 | 7.39 on 03/25/26 | 28.66 on 02/19/26 | ||
| High | 23.99 on 02/15/17 | 10.16 on 10/03/25 | 91.00 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,663,416 | 5,607,938 | 4,519,832 | ||
| Shares Outstanding, K | 194,390 | 680,575 | 106,374 | ||
| Annual Sales | 118,800,000 | 8,512,650,000 | 761,410,000 | ||
| Annual Net Income | -231,160,000 | 565,700,000 | 99,650,000 | ||
| Last Quarter Sales | 46,020,000 | 2,304,030,000 | 202,130,000 | ||
| Last Quarter Net Income | -27,830,000 | 221,480,000 | 24,290,000 | ||
| 60-Month Beta | 2.16 | 0.70 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/07/16 | 0.19 on 07/28/25 | 0.20 on 02/24/26 | ||
| Latest Earnings Date | 02/28/17 | 02/25/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | 0.142 on 08/12/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 08/12/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 51.20 | ||